Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1498733

Cover Image

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1498733

Artificial Intelligence in Precision Medicine Market, By Technology, By Component, By Therapeutic Application, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

PUBLISHED:
PAGES: 322 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3250
PDF (5 User License)
USD 4650
PDF & Excel (Enterprise User License)
USD 5650

Add to Cart

REPORT HIGHLIGHT

Artificial Intelligence in Precision Medicine Market size was valued at USD 1,854.2 Million in 2023, expanding at a CAGR of 20.10% from 2024 to 2032.

Precision medicine has never been the same since artificial intelligence (AI) has made it possible to evaluate enormous volumes of biological, clinical, and lifestyle data to customize medicines and treatments for specific patients. With the use of AI algorithms, precision medicine practitioners can now sift and decipher intricate genetic and molecular data, find patterns, and create individualized predictions regarding a patient's prognosis, likelihood of developing a disease, and reaction to various therapies. Clinical professionals can benefit from AI-powered systems that can forecast probable side effects or problems, make more accurate diagnoses, and choose targeted therapies by integrating data from several sources, including wearables, electronic health records, and genetic sequencing.

Artificial Intelligence in Precision Medicine Market- Market Dynamics

Growing Chronic Diseases Prevalence to Propel Market Growth

Chronic diseases, also known as non-communicable diseases (NCDs), are a broad category of medical ailments that include respiratory disorders, diabetes, cancer, and cardiovascular diseases. Their protracted length, gradual advancement, and constant need for medical care and supervision define them. The World Health Organization (WHO) reports that nearly 71% of deaths worldwide are attributable to chronic diseases, with low- and middle-income nations accounting for an astounding 85% of these deaths. Chronic illnesses have a significant negative socioeconomic impact on people's quality of life, as well as on healthcare systems, workforce productivity, and individual and family quality of life. The healthcare sector has seen a significant transformation due to artificial intelligence, particularly in the areas of machine learning and deep learning. Al is capable of producing predictive models, processing and analyzing enormous datasets, and identifying intricate patterns. With Al's application to precision medicine, more precise diagnoses and individualized therapeutic interventions can be achieved by exploring the complex interactions among genetic composition, illness susceptibility, and treatment outcomes. Genomic research represents one of the major uses of Al in precision medicine. Additionally, the use of Al in precision medicine will probably grow as long as technology keeps developing. Real-time monitoring, wearable technology, and electronic health record integration will all work together to offer Al algorithms a constant stream of data to evaluate, allowing for prompt treatment plan modifications and interventions.

Artificial Intelligence in Precision Medicine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 20.10% over the forecast period (2024-2032)

Based on technology segmentation, the deep learning category was predicted to show maximum market share in the year 2023

Based on component segmentation, the software category was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Artificial Intelligence in Precision Medicine Market- Segmentation Analysis:

The Global Artificial Intelligence in Precision Medicine Market is segmented on the basis of Technology, Component, Therapeutic Application, and Region.

The market is divided into two categories based on technology: Machine Learning, Querying Method, Deep Learning, Context-Aware Processing, and Natural Language Processing. The deep learning category dominates the market. The segment's growth can be attributed to its high processing power, advancements in data center capabilities, and its capacity for automated processes. Modern deep learning algorithms can now integrate and model several data sets from an individual across time and modalities, improving prediction accuracy and therapy recommendations for specific patients.

The market is divided into the following categories based on therapeutic application: Oncology, Neurology, Cardiology, Respiratory, and Others. The oncology category dominates the market and is likely to maintain its dominance during the forecast period. Artificial intelligence (AI) in oncology is expected to drive the industry's growth throughout the projected period by facilitating more rapid and accurate cancer diagnosis, which in turn improves patient income. The major factors that are anticipated to drive the oncology industry are the rising incidence of cancer and the expanding medical infrastructure. Additionally, it is anticipated that there will be a serious scarcity of medical staff-such as doctors and nurses-in hospital facilities, which will raise demand for technology.

Artificial Intelligence in Precision Medicine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for artificial intelligence in precision medicine. The strategic presence of major players, including Abbott, Danone, Targeted Medical Pharma, Inc., Nestle, and Mead Johnson & Company, LLC, is credited with the market's growth. For instance, the biosimulation pioneer Certara, Inc. announced in July 2022 that it would be working with Memorial Sloan Kettering Cancer Center for two years to develop new biosimulation software. Through this partnership, businesses may create a biosimulation platform for the treatment of CAR T cells. Moreover, immune system T-cells that have undergone a special modification are used in CAR T-cell therapy, also referred to as immunotherapy, to treat specific forms of blood cancer.

In addition, the artificial intelligence in precision medicine market is anticipated to expand at the fastest rate in the world during the projected period in Europe because of the population's increasing ability to pay for healthcare and the pace at which technology is developing. The growing government initiatives are fueling the expansion of the regional market. In order to develop innovative cancer detection, diagnosis, and treatment solutions-especially those based on artificial intelligence-innovators and researchers need assistance translating real-world oncology data on the quality and scale required. This is the goal of the European Cancer Imaging Initiative.

Artificial Intelligence in Precision Medicine Market- Competitive Landscape:

Numerous key players, including Intel Corporation, Insilico Medicines, NVIDIA Corporation, Microsoft Corporation, and AstraZeneca, among others, produce goods or introduce novel applications of AI in precision medicine. These companies have developed several strategies to increase their market share. These developments in the market include the introduction of new products, contracts, large investments, mergers and acquisitions, and partnerships with other organizations. One attractive strategy for growing and surviving in the rising market climate is to offer cost-effective products. Furthermore, during the projected period, the market is expected to reach a notable extent due to the product approvals granted by regulatory authorities.

Recent Developments:

January 2024: The Siemens Healthineers-Computational Data Sciences (CDS) Collaborative Laboratory was launched by Siemens Healthineers and the Indian Institute of Science (IISc) in Bangalore. This is a ground-breaking project that combines artificial intelligence (AI) and precision medicine. Committed to developing open-source AI tools, the CDS collaborative laboratory is focused on progressing in the area of neuroimaging. These will be key instruments in automating the accurate delineation of abnormal findings in neuroimaging data.

March 2023: In order to help pharmaceutical businesses, biotech companies, and other stakeholders expedite drug discovery and precision medicine, Google Cloud has introduced two new artificial intelligence (Al)-based life sciences solutions. Research teams can more accurately identify the role of amino acids with the aid of the target & lead identification suite. It is anticipated that this approach will improve its service portfolio and help to solidify its position in the market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Intel Corporation

Insilico Medicines

NVIDIA Corporation

Zephyr AI

Atomwise Inc

Microsoft Corporation

AtraZeneca

Enlitic Inc.

Modernizing machine Inc.

BioXcel Therapeutics, Inc.

Others

GLOBAL ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Machine Learning
  • Querying Method
  • Deep Learning
  • Context-Aware Processing
  • Natural Language Processing

GLOBAL ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Hardware
  • Software
  • Service

GLOBAL ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Neurology
  • Cardiology
  • Respiratory
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA
Product Code: ANV2902

Table of Contents

1. Artificial Intelligence in Precision Medicine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Artificial Intelligence in Precision Medicine Market Snippet by Technology
    • 2.1.2. Artificial Intelligence in Precision Medicine Market Snippet by Component
    • 2.1.3. Artificial Intelligence in Precision Medicine Market Snippet by Therapeutic Application
    • 2.1.4. Artificial Intelligence in Precision Medicine Market Snippet by Country
    • 2.1.5. Artificial Intelligence in Precision Medicine Market Snippet by Region
  • 2.2. Competitive Insights

3. Artificial Intelligence in Precision Medicine Key Market Trends

  • 3.1. Artificial Intelligence in Precision Medicine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Artificial Intelligence in Precision Medicine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Artificial Intelligence in Precision Medicine Market Opportunities
  • 3.4. Artificial Intelligence in Precision Medicine Market Future Trends

4. Artificial Intelligence in Precision Medicine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Artificial Intelligence in Precision Medicine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Artificial Intelligence in Precision Medicine Market Landscape

  • 6.1. Artificial Intelligence in Precision Medicine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Artificial Intelligence in Precision Medicine Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 7.1.2. Machine Learning
    • 7.1.3. Querying Method
    • 7.1.4. Deep Learning
    • 7.1.5. Context-Aware Processing
    • 7.1.6. Natural Language Processing

8. Artificial Intelligence in Precision Medicine Market - By Component

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Component, 2023 & 2032 (%)
    • 8.1.2. Hardware
    • 8.1.3. Software
    • 8.1.4. Service

9. Artificial Intelligence in Precision Medicine Market - By Therapeutic Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Therapeutic Application, 2023 & 2032 (%)
    • 9.1.2. Oncology
    • 9.1.3. Neurology
    • 9.1.4. Cardiology
    • 9.1.5. Respiratory
    • 9.1.6. Others

10. Artificial Intelligence in Precision Medicine Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Artificial Intelligence in Precision Medicine Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Artificial Intelligence in Precision Medicine Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Artificial Intelligence in Precision Medicine Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Artificial Intelligence in Precision Medicine Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Artificial Intelligence in Precision Medicine Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Artificial Intelligence in Precision Medicine Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Intel Corporation
    • 11.2.2. Insilico Medicines
    • 11.2.3. NVIDIA Corporation
    • 11.2.4. Zephyr AI
    • 11.2.5. Atomwise Inc
    • 11.2.6. Microsoft Corporation
    • 11.2.7. AtraZeneca
    • 11.2.8. Enlitic Inc.
    • 11.2.9. Modernizing machine Inc.
    • 11.2.10. BioXcel Therapeutics, Inc.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
Product Code: ANV2902

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Artificial Intelligence in Precision Medicine Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Artificial Intelligence in Precision Medicine Market, by Technology 2019-2032 (USD Million)
  • TABLE Artificial Intelligence in Precision Medicine Market: Component Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Component
  • TABLE Global Artificial Intelligence in Precision Medicine Market, by Component 2019-2032 (USD Million)
  • TABLE Artificial Intelligence in Precision Medicine Market: Therapeutic Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Application
  • TABLE Global Artificial Intelligence in Precision Medicine Market, by Therapeutic Application 2019-2032 (USD Million)
  • TABLE Artificial Intelligence in Precision Medicine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Artificial Intelligence in Precision Medicine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Artificial Intelligence in Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Artificial Intelligence in Precision Medicine Market, by Technology, 2019-2032 (USD Million)
  • TABLE North America Artificial Intelligence in Precision Medicine Market, by Component, 2019-2032 (USD Million)
  • TABLE North America Artificial Intelligence in Precision Medicine Market, by Therapeutic Application, 2019-2032 (USD Million)
  • TABLE Europe Artificial Intelligence in Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Artificial Intelligence in Precision Medicine Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe Artificial Intelligence in Precision Medicine Market, by Component, 2019-2032 (USD Million)
  • TABLE Europe Artificial Intelligence in Precision Medicine Market, by Therapeutic Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Artificial Intelligence in Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Artificial Intelligence in Precision Medicine Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific Artificial Intelligence in Precision Medicine Market, by Component, 2019-2032 (USD Million)
  • TABLE Asia Pacific Artificial Intelligence in Precision Medicine Market, by Therapeutic Application, 2019-2032 (USD Million)
  • TABLE Latin America Artificial Intelligence in Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Artificial Intelligence in Precision Medicine Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America Artificial Intelligence in Precision Medicine Market, by Component, 2019-2032 (USD Million)
  • TABLE Latin America Artificial Intelligence in Precision Medicine Market, by Therapeutic Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Artificial Intelligence in Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Artificial Intelligence in Precision Medicine Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Artificial Intelligence in Precision Medicine Market, by Component, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Artificial Intelligence in Precision Medicine Market, by Therapeutic Application, 2019-2032 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!